ERN ReCONNET
COVID-19
European League Against Rheumatism recommendations
EULAR recommendations
The European League Against Rheumatism (EULAR) has developed a Rheumatic Musculoskeletal Diseases and COVID-19 repository where you can find the EULAR guidance for patients and an array of useful resources about the current COVID-19 outbreak to give patients with Rheumatic Musculoskeletal Diseases the best possible care.
EULAR has developed the EULAR – COVID-19 Database, a European paediatric and adult database (in collaboration with the Pediatric Rheumatology European Society) to monitor and report on outcomes of COVID-19 occurring in patients with rheumatic and musculoskeletal diseases. There is an urgent need to understand outcomes of patients who acquire infection and are receiving steroids, synthetic or biologic disease-modifying anti-rheumatic drugs and non-steroidal anti-inflammatory. This will help guide rheumatologists and other clinicians such as specialist nurses in advising and caring for their patients.
[foogallery id=”8496″]
EULAR has developed the EULAR – COVID-19 Database, a European paediatric and adult database (in collaboration with the Pediatric Rheumatology European Society) to monitor and report on outcomes of COVID-19 occurring in patients with rheumatic and musculoskeletal diseases. There is an urgent need to understand outcomes of patients who acquire infection and are receiving steroids, synthetic or biologic disease-modifying anti-rheumatic drugs and non-steroidal anti-inflammatory. This will help guide rheumatologists and other clinicians such as specialist nurses in advising and caring for their patients.
